Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
Genetic Risk Factor for Liver Disease for Patients With Cystic Fibrosis
Gastroenterology, 10/27/09
Lang LH – A genetic analysis indicates that a certain gene variation in patients with cystic fibrosis may significantly increase their risk of developing severe liver disease, according to a study in the September 9 issue of JAMA.
Related Articles
Vitamin D supplementation for cystic fibrosis
Cochrane Reviews, 10/28/09
Relevance Score: 69%
Inspire Announces Presentation at the North American Cystic Fibrosis Conference and Provides Enrollment Update for Phase 3 Cystic Fibrosis Trial
Inspire, 10/16/09
Relevance Score: 69%
Pulmonary nocardiosis in cystic fibrosis
Journal of Cystic Fibrosis, 10/07/09
Relevance Score: 69%
Cystic fibrosis neutrophils have normal intrinsic reactive oxygen species generation
European Respiratory Journal, 10/23/09
Relevance Score: 68%
Impact of Socioeconomic Status, Race, and Ethnicity on Quality of Life in Patients with Cystic Fibrosis in the United States
Chest, 10/15/09
Relevance Score: 68%
Today in Gastroenterology...keeping you current
Receive free subspecialty "5-minute updates" via email
Un-promoted issues in inflammatory bowel disease: opportunities to optimize care
Internal Medicine Journal, 03/22/10
Zinc Influences the Innate Immune Responses in Children with Enterotoxigenic Escherichia coli-Induced Diarrhea
The Journal of Nutrition, 03/22/10
Clinical trial: irsogladine maleate, a mucosal protective drug, accelerates gastric ulcer healing after treatment for eradication of Helicobacter pylori infection - the results of a multicentre, double-blind, randomized clinical trial (IMPACT study)
Alimentary Pharmacology and Therapeutics, 03/22/10
Today in Hepatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Clinical trial: short-term effects of combination of satavaptan, a selective vasopressin V2 receptor antagonist, and diuretics on ascites in patients with cirrhosis without hyponatraemia - a randomized, double-blind, placebo-controlled study
Alimentary Pharmacology and Therapeutics, 03/22/10
Liver transplantation for polycystic liver and massive hepatomegaly
World Journal of Gastroenterology, 03/22/10
Interferon-alpha induced severe thrombocytopenia: A case report and review of the literature
World Journal of Gastroenterology, 03/22/10
Today in Gastroenterology...keeping you current
Receive free subspecialty "5-minute updates" via email
Modified-Irinotecan/Fluorouracil/Levoleucovorin Therapy as Ambulatory Treatment for Metastatic Colorectal Cancer: Results of Phase I and II Studies
Clinical Drug Investigation, 03/22/10
Omeprazole-Mg 20.6 mg is superior to lansoprazole 15 mg for control of gastric acid: a comparison of over-the-counter doses of proton pump inhibitors
Alimentary Pharmacology and Therapeutics, 03/22/10
Un-promoted issues in inflammatory bowel disease: opportunities to optimize care
Internal Medicine Journal, 03/22/10
Today in Gastroenterology...keeping you current
Receive free subspecialty "5-minute updates" via email
Zinc Influences the Innate Immune Responses in Children with Enterotoxigenic Escherichia coli-Induced Diarrhea
The Journal of Nutrition, 03/22/10
Un-promoted issues in inflammatory bowel disease: opportunities to optimize care
Internal Medicine Journal, 03/22/10
Clinical trial: irsogladine maleate, a mucosal protective drug, accelerates gastric ulcer healing after treatment for eradication of Helicobacter pylori infection - the results of a multicentre, double-blind, randomized clinical trial (IMPACT study)
Alimentary Pharmacology and Therapeutics, 03/22/10
Today in Gastroenterology...keeping you current
Receive free subspecialty "5-minute updates" via email
Un-promoted issues in inflammatory bowel disease: opportunities to optimize care
Internal Medicine Journal, 03/22/10
Clinical trial: short-term effects of combination of satavaptan, a selective vasopressin V2 receptor antagonist, and diuretics on ascites in patients with cirrhosis without hyponatraemia - a randomized, double-blind, placebo-controlled study
Alimentary Pharmacology and Therapeutics, 03/22/10
Clinical trial: irsogladine maleate, a mucosal protective drug, accelerates gastric ulcer healing after treatment for eradication of Helicobacter pylori infection - the results of a multicentre, double-blind, randomized clinical trial (IMPACT study)
Alimentary Pharmacology and Therapeutics, 03/22/10
Today in Gastroenterology...keeping you current
Receive free subspecialty "5-minute updates" via email
Un-promoted issues in inflammatory bowel disease: opportunities to optimize care
Internal Medicine Journal, 03/22/10
Zinc Influences the Innate Immune Responses in Children with Enterotoxigenic Escherichia coli-Induced Diarrhea
The Journal of Nutrition, 03/22/10
Omeprazole-Mg 20.6 mg is superior to lansoprazole 15 mg for control of gastric acid: a comparison of over-the-counter doses of proton pump inhibitors
Alimentary Pharmacology and Therapeutics, 03/22/10
Today in Cystic Fibrosis...keeping you current
Receive free subspecialty "5-minute updates" via email
Neuraminidase inhibitors for the treatment of influenza infection in people with cystic fibrosis
Cochrane Reviews, 03/22/10
Pulmonary fibrosis in systemic sclerosis: Diagnosis & management
Respiratory Medicine CME, 03/22/10
Comparative demographics of the European cystic fibrosis population: a cross-sectional database analysis
The Lancet, 03/22/10
Article Search
Sponsor


See Latest Articles


